164 related articles for article (PubMed ID: 2574358)
1. Effect of GM-CSF on circulating granulocyte-monocyte progenitors in autologous bone marrow transplantation.
Nemunaitis J; Appelbaum F; Singer J
Lancet; 1989 Dec; 2(8676):1405-6. PubMed ID: 2574358
[No Abstract] [Full Text] [Related]
2. Clinical applications of colony-stimulating factors.
Groopman JE
Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
[TBL] [Abstract][Full Text] [Related]
3. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
[No Abstract] [Full Text] [Related]
5. Clinical use of GM-CSF in autologous bone marrow transplantation.
Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF boosts survival rate in marrow transplant failures.
Oncology (Williston Park); 1990 Apr; 4(4):137. PubMed ID: 2143923
[No Abstract] [Full Text] [Related]
7. Human GM-CSF in vivo: identification of the target cells and of their kinetics of response.
Aglietta M; Bussolino F; Piacibello W; Aprá F; Sanavio F; Stacchini A; Monzeglio C; Carnino F; Gavosto F
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():283-90; discussion 290-2. PubMed ID: 2182741
[TBL] [Abstract][Full Text] [Related]
8. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF and G-CSF in hematology and oncology.
Offner FC; Van Hove WZ
Acta Clin Belg; 1989; 44(5):318-25. PubMed ID: 2481926
[TBL] [Abstract][Full Text] [Related]
10. In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts.
Blazar BR; Kersey JH; McGlave PB; Vallera DA; Lasky LC; Haake RJ; Bostrom B; Weisdorf DR; Epstein C; Ramsay NK
Blood; 1989 Feb; 73(3):849-57. PubMed ID: 2644992
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF administration after transplantation of purged autologous marrow.
Januszewicz EH
Blood; 1990 Jan; 75(1):319-20. PubMed ID: 2403820
[No Abstract] [Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
[No Abstract] [Full Text] [Related]
13. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
Antin JH; Smith BR; Holmes W; Rosenthal DS
Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic colony-stimulating factors.
Andreeff M; Welte K
Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
[No Abstract] [Full Text] [Related]
15. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial.
Steis RG; VanderMolen LA; Longo DL; Clark JW; Smith JW; Kopp WC; Ruscetti FW; Creekmore SP; Elwood LJ; Hursey J
J Natl Cancer Inst; 1990 Apr; 82(8):697-703. PubMed ID: 2138680
[TBL] [Abstract][Full Text] [Related]
17. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF).
Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A
Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967
[No Abstract] [Full Text] [Related]
18. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
Yamashita J; Kawamura T; Shoin K
No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
[No Abstract] [Full Text] [Related]
19. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense.
Gutterman J; Vadhan-Raj S; Logothetis C; Anaissle E; Estey E; Talpaz M; Kurzrock R
Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey C
Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
